Atlas Brown Inc. Acquires 2,160 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Atlas Brown Inc. raised its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 6.6% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 35,044 shares of the pharmacy operator’s stock after purchasing an additional 2,160 shares during the quarter. Atlas Brown Inc.’s holdings in Walgreens Boots Alliance were worth $1,649,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the business. Vanguard Group Inc. grew its holdings in shares of Walgreens Boots Alliance by 1.1% in the 2nd quarter. Vanguard Group Inc. now owns 58,948,812 shares of the pharmacy operator’s stock valued at $3,101,298,000 after buying an additional 628,017 shares during the period. FMR LLC lifted its position in Walgreens Boots Alliance by 4.1% during the 2nd quarter. FMR LLC now owns 16,576,185 shares of the pharmacy operator’s stock worth $872,073,000 after buying an additional 652,664 shares in the last quarter. Geode Capital Management LLC lifted its position in Walgreens Boots Alliance by 2.5% during the 2nd quarter. Geode Capital Management LLC now owns 11,705,342 shares of the pharmacy operator’s stock worth $613,949,000 after buying an additional 289,532 shares in the last quarter. Invesco Ltd. lifted its position in Walgreens Boots Alliance by 16.8% during the 2nd quarter. Invesco Ltd. now owns 8,027,871 shares of the pharmacy operator’s stock worth $422,347,000 after buying an additional 1,153,930 shares in the last quarter. Finally, Morgan Stanley lifted its position in Walgreens Boots Alliance by 6.1% during the 2nd quarter. Morgan Stanley now owns 5,715,897 shares of the pharmacy operator’s stock worth $300,713,000 after buying an additional 328,328 shares in the last quarter. Institutional investors own 55.53% of the company’s stock.

In related news, Director Nancy M. Schlichting sold 2,725 shares of the company’s stock in a transaction that occurred on Friday, November 19th. The shares were sold at an average price of $47.16, for a total transaction of $128,511.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 17.53% of the company’s stock.

A number of brokerages have recently issued reports on WBA. Robert W. Baird reaffirmed a “buy” rating and issued a $68.00 target price on shares of Walgreens Boots Alliance in a report on Friday, September 3rd. Truist Securities upped their target price on shares of Walgreens Boots Alliance from $52.00 to $56.00 and gave the company a “hold” rating in a report on Friday, October 15th. Credit Suisse Group reaffirmed a “hold” rating and issued a $48.00 target price on shares of Walgreens Boots Alliance in a report on Friday, September 24th. TheStreet cut shares of Walgreens Boots Alliance from a “b-” rating to a “c” rating in a report on Friday, November 19th. Finally, Zacks Investment Research cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $50.00 target price on the stock. in a report on Wednesday, October 20th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and a consensus target price of $55.00.

Shares of WBA stock traded down $0.77 during trading hours on Thursday, hitting $46.62. 7,990,562 shares of the company’s stock traded hands, compared to its average volume of 5,836,886. Walgreens Boots Alliance, Inc. has a 12 month low of $37.89 and a 12 month high of $57.05. The stock’s 50 day simple moving average is $48.26 and its 200 day simple moving average is $49.67. The stock has a market cap of $40.35 billion, a PE ratio of 15.91, a price-to-earnings-growth ratio of 2.28 and a beta of 0.52. The company has a quick ratio of 0.35, a current ratio of 0.72 and a debt-to-equity ratio of 0.32.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, October 14th. The pharmacy operator reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.02 by $0.15. The firm had revenue of $34.26 billion during the quarter, compared to analysts’ expectations of $33.39 billion. Walgreens Boots Alliance had a net margin of 1.85% and a return on equity of 20.76%. The business’s revenue was up 12.8% on a year-over-year basis. During the same period last year, the company earned $1.02 earnings per share. As a group, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 4.96 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 10th. Shareholders of record on Monday, November 15th will be given a $0.477 dividend. This represents a $1.91 annualized dividend and a yield of 4.09%. The ex-dividend date of this dividend is Friday, November 12th. Walgreens Boots Alliance’s dividend payout ratio is 65.19%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA and Retail Pharmacy International. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.

See Also: Dividend

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.